As far as we know, this is the first pan-cancer study to analyze VDR expression and the association with clinical outcomes, immune infiltration, tumor microenvironment and gene set enrichment based on online databases and R software across 33 types of human cancers. This evidence concerns the gene VDR and neoplasm.